About this trial
This study aims to investigate the effects of omega-3 fatty acid supplementation on muscle performance, neuromuscular function, inflammation, and oxidative stress at rest and after eccentric exercise. The findings may provide insights into the role of omega-3 fatty acids in muscle function, physiology, and metabolism following muscle-damaging exercise. Additionally, the effects of omega-3 fatty acids on cardiovascular health will be investigated.
Eligibility criteria
Qualifiers
Body Mass Index (BMI) within the normal range (18.5-25 kg/m²).
Healthy individuals without severe medical conditions (e.g., diabetes, coronary artery disease, hypertension, neuromuscular disorders).
No musculoskeletal injury in the lower limbs (e.g., bone fracture, tendon rupture, grade III muscle strain) within the last 6 months before enrollment.
Negative responses to all questions on the PAR-Q questionnaire indicating no contraindications to participating in exercise testing.
Disqualifiers
Use of any pharmaceutical medications (e.g., statins, aspirin, ibuprofen).
Use of dietary supplements (e.g., protein, vitamins) within the last 3 months before enrollment.
Participation in a structured training program involving more than three training sessions per week during the study period.
Following a special diet (e.g., intermittent fasting, ketogenic diet, vegetarian diet).
Trial design
Treatments tested in this trial
- Omega-3
- Placebo comparator